Q32 Bio Inc. (QTTB) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Q32 Bio Inc. (QTTB) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

QTTB Cash Flow Statement

Q32 Bio Inc. (QTTB) cash flow statement — 10-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-9.42M	-6.34M	-6.18M	-4.23M	-10.65M	-12.48M	-11.43M	-19.52M	-22.21M	-14.55M	-10.71M	15.9M	2.19M	-12.5M	9.52M	-24.93M	-30.85M	-30.68M	-30.43M	-25.39M
Operating CF Margin %	-	-	-11.5%	-	-	-	-	-	-	-	73.08%	855.35%	68.36%	-424.02%	1187.03%	-3108.73%	-3846.13%	-3825.94%	-3794.26%	-1513.83%
Operating CF Growth %	11.58%	49.18%	45.92%	78.33%	52.05%	14.22%	-6.65%	-222.77%	-1113.87%	-16.45%	-212.55%	163.78%	107.1%	59.28%	131.28%	1.79%	-27.93%	-2.89%	-162.06%	12.12%
Net Income	-16.55M	-7.61M	57.73M	-7.39M	-9.49M	-11.03M	-14.19M	-17.59M	-16.98M	1.03M	-27.07M	-14.03M	-5.81M	-6.84M	-9.69M	-33.73M	-29.09M	92.11M	-33.58M	-30.61M
Depreciation & Amortization	175K	33K	90K	91K	91K	119K	120K	123K	121K	123K	124K	124K	124K	127K	128K	635K	786K	545K	2.4M	2.4M
Stock-Based Compensation	3.23M	1.55M	1.47M	1.18M	1.27M	1.34M	1.25M	1.38M	1.34M	417K	0	301K	0	296K	318K	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	1.13M	253K	-65.28M	204K	790K	-687K	416K	-153K	63K	-15.54M	1.89M	6.4M	16.94M	201K	1.59M	4.17M	4.38M	-126.57M	5.02M	4.48M
Working Capital Changes	2.6M	-568K	-190K	1.69M	-3.31M	-2.23M	974K	-3.28M	-6.76M	-576K	14.34M	23.11M	-9.06M	-6.28M	17.18M	3.99M	-6.92M	3.23M	-4.26M	-1.65M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	686K	-226K	-94K	63K	-1.8M	-277K	1.73M	-1.23M	-2.48M	928K	1.64M	1.13M	-3.22M	-823K	386K	1.07M	-6.06M	7.7M	-1.36M	-2.11M
Cash from Investing	0	0	7M	0	0	0	-2K	9.94M	9.89M	97K	0	-1K	-31.38M	-5K	19K	-108.22M	-41.37M	168.31M	43.66M	4.52M
Capital Expenditures	0	0	0	0	0	0	-2K	-58K	-15K	0	0	-1K	224K	-5K	0	-6K	-121K	-1.15M	-338K	-477K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	0.05%	6.99%	0.17%	-	0.75%	15.09%	143.27%	42.14%	28.44%
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	130M	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	7M	0	0	0	0	0	0	0	0	0	0	0	19K	0	0	0	0	0
Cash from Financing	67.39M	8.8M	-1.56M	-1.56M	0	0	317K	997K	-5.52M	99.35M	76K	300K	-120K	15K	16.67M	124K	0	440K	1K	379K
Debt Issued (Net)	-9.82M	-1.56M	-1.56M	-1.56M	0	0	0	0	0	7M	0	300K	0	0	16.67M	0	0	0	0	0
Equity Issued (Net)	77.21M	10.36M	0	0	0	0	0	0	0	42M	76K	0	-120K	0	0	124K	0	440K	1K	379K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	317K	997K	-5.52M	50.35M	0	0	0	15K	0	0	0	0	0	0
Net Change in Cash	57.97M	2.45M	-742K	-5.79M	-10.65M	-12.48M	-11.11M	-8.58M	-17.85M	84.89M	-3.49M	-47.69M	37.34M	-12.49M	26.21M	-133.03M	-71.94M	139.75M	12.55M	-20.48M
Free Cash Flow	-9.42M	-6.34M	-6.18M	-4.23M	-10.65M	-12.48M	-11.43M	-19.58M	-22.23M	-14.55M	-10.71M	15.9M	2.42M	-12.5M	9.52M	-24.94M	-30.97M	-31.83M	-30.77M	-25.86M
FCF Margin %	-	-	-11.5%	-	-	-	-	-	-	-	73.08%	855.3%	75.35%	-424.19%	1187.03%	-3109.48%	-3861.22%	-3969.2%	-3836.41%	-1542.28%
FCF Growth %	11.58%	49.18%	45.93%	78.4%	52.09%	14.22%	-6.67%	-223.14%	-1020.46%	-16.4%	-212.55%	163.76%	107.8%	60.73%	130.94%	3.58%	-24.49%	-3.89%	-144.83%	10.95%
FCF per Share	-0.46	-0.45	-0.47	-0.35	-0.87	-1.02	-1.05	-1.62	-1.86	-1.22	-3.32	4.95	0.75	-3.90	2.98	-7.81	-9.71	-9.90	-9.69	-8.15
FCF Conversion (FCF/Net Income)	1.05x	0.83x	-0.11x	0.57x	1.12x	1.13x	0.81x	1.11x	1.31x	-14.14x	0.40x	-1.13x	-0.38x	1.83x	-0.28x	0.74x	1.06x	-0.33x	0.91x	0.83x
Interest Paid	0	0	0	0	259K	247K	254K	264K	0	115K	0	0	0	119K	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0